{"id":"https://openalex.org/W2043296164","doi":"https://doi.org/10.1089/cbr.1999.14.121","title":"In Vitro and In Vivo Enhancement of Canine Pulmonary Alveolar Macrophage Cytotoxic Activity Against Canine Osteosarcoma Cells","display_name":"In Vitro and In Vivo Enhancement of Canine Pulmonary Alveolar Macrophage Cytotoxic Activity Against Canine Osteosarcoma Cells","alternate_titles":[],"publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W2043296164","doi":"https://doi.org/10.1089/cbr.1999.14.121","mag":"2043296164","pmid":"https://pubmed.ncbi.nlm.nih.gov/10850295"},"language":"en","primary_location":{"id":"doi:10.1089/cbr.1999.14.121","doi":"https://doi.org/10.1089/cbr.1999.14.121","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.1999.14.121","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043296164"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052093839","display_name":"Ilene D. Kurzman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ilene D. Kurzman","raw_affiliation_strings":["Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53706, USA. kurzmani@svm.vetmed.wisc.edu","Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 53706, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53706, USA. kurzmani@svm.vetmed.wisc.edu","institution_ids":["https://openalex.org/I135310074"]},{"raw_affiliation_string":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 53706, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073712458","display_name":"Fushun Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fushun Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047472326","display_name":"David M. Vail","orcid":"https://orcid.org/0000-0002-1964-3693","observed_orcids":["https://orcid.org/0000-0002-1964-3693"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David M. Vail","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038318942","display_name":"E. Gregory MacEwen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Gregory MacEwen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2074,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.44058745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"14","issue":"2","first_page":"121","last_page":"128"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.7738999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.7738999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.21789999306201935,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canine-osteosarcoma","display_name":"canine osteosarcoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/alveolar-macrophages","display_name":"alveolar macrophages","score":0.9940000176429749},{"id":"https://openalex.org/keywords/macrophage-mediated-cytotoxicity","display_name":"macrophage cytotoxicity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.6470000147819519},{"id":"https://openalex.org/keywords/recombinant-tnf-alpha","display_name":"recombinant TNF-alpha","score":0.906000018119812},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8669999837875366},{"id":"https://openalex.org/keywords/macrophage-activation","display_name":"macrophage activation","score":0.7639999985694885},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/canine-cancer","display_name":"canine cancer","score":0.3970000147819519},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6420472264289856},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.594222903251648},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5740541219711304},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5578052997589111},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5349658131599426},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5183659195899963},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5126813650131226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5037848353385925},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.49127882719039917},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.48328307271003723},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.4600429832935333},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4293777346611023},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3864619731903076},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3797556757926941},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3219717741012573},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2591884732246399},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2193533480167389},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14435169100761414},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000119","descriptor_name":"Acetylmuramyl-Alanyl-Isoglutamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008262","descriptor_name":"Macrophage Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010714","descriptor_name":"Phosphatidylethanolamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010714","descriptor_name":"Phosphatidylethanolamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010714","descriptor_name":"Phosphatidylethanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":true},{"descriptor_ui":"D013268","descriptor_name":"Stimulation, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016676","descriptor_name":"Macrophages, Alveolar","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016676","descriptor_name":"Macrophages, Alveolar","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D016676","descriptor_name":"Macrophages, Alveolar","qualifier_ui":"Q000637","qualifier_name":"transplantation","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cbr.1999.14.121","doi":"https://doi.org/10.1089/cbr.1999.14.121","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.1999.14.121","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"pmid:10850295","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10850295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biotherapy & radiopharmaceuticals","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W206142350","https://openalex.org/W1497680781","https://openalex.org/W1569917781","https://openalex.org/W1626480140","https://openalex.org/W1632674887","https://openalex.org/W1886587279","https://openalex.org/W1946967684","https://openalex.org/W1964149427","https://openalex.org/W1965608693","https://openalex.org/W1966897576","https://openalex.org/W1967253561","https://openalex.org/W1979836631","https://openalex.org/W1984187728","https://openalex.org/W1985496339","https://openalex.org/W2026924138","https://openalex.org/W2104729679","https://openalex.org/W2125215650","https://openalex.org/W2144364836","https://openalex.org/W2144565615","https://openalex.org/W2144991078","https://openalex.org/W2159069239","https://openalex.org/W2344904906","https://openalex.org/W2401255636","https://openalex.org/W2403137753","https://openalex.org/W2412190227","https://openalex.org/W2419637041","https://openalex.org/W2584278415","https://openalex.org/W4391199625"],"related_works":["https://openalex.org/W2077428327","https://openalex.org/W2560513768","https://openalex.org/W2129260660","https://openalex.org/W2088676851","https://openalex.org/W3200593920","https://openalex.org/W2889554260","https://openalex.org/W1979836631","https://openalex.org/W1780629197","https://openalex.org/W2061052008"],"abstract_inverted_index":{"The":[0],"combination":[1,93],"of":[2,31,49,77,161,181],"chemotherapy":[3,152],"with":[4,82,94,123,139,154],"immunotherapy":[5,156],"may":[6],"offer":[7],"an":[8,155],"advantage":[9],"over":[10],"either":[11],"therapy":[12],"alone":[13,90],"and":[14,66,103,117,164,171],"provide":[15],"a":[16,28,151,166],"greater":[17],"potential":[18],"for":[19,149,158,168,176],"total":[20],"tumor":[21,24],"eradication.":[22],"Monocyte/macrophage-mediated":[23],"cell":[25],"killing":[26],"is":[27],"major":[29],"mechanism":[30],"the":[32,42,72,83,147,159,178],"host's":[33],"defense":[34],"against":[35,45,113,131],"primary":[36],"and/or":[37],"metastatic":[38,162],"neoplasia.":[39],"We":[40,69],"evaluated":[41,71],"tumoricidal":[43,75],"activity":[44,76,130,180],"canine":[46,50,61,110,114],"osteosarcoma":[47,115,132],"cells":[48,133],"pulmonary":[51],"alveolar":[52],"macrophages":[53],"(PAM)":[54],"exposed":[55],"in":[56,73,92,108],"vitro":[57,109],"to":[58,136],"two":[59],"recombinant":[60],"(rc)":[62],"cytokines":[63],"(rcTNF":[64],"alpha":[65,102,170],"rcIFN":[67,104],"gamma).":[68],"also":[70],"vivo":[74],"PAM":[78,111,119],"from":[79,120],"dogs":[80,121,137],"treated":[81,122,138],"macrophage":[84],"activator,":[85],"liposome-encapsulated":[86],"muramyl":[87],"tripeptide-phosphatidyl-ethanolamine":[88],"(L-MTP-PE)":[89],"or":[91,141],"doxorubicin":[95],"(DOX).":[96],"This":[97],"study":[98],"demonstrated":[99],"that":[100,118],"rcTNF":[101],"gamma":[105,173],"significantly":[106],"enhance":[107],"cytotoxicity":[112],"cells,":[116],"DOX":[124,140],"+":[125],"L-MTP-PE":[126,142],"have":[127],"enhanced":[128],"cytotoxic":[129],"when":[134],"compared":[135],"alone.":[143],"These":[144],"findings":[145],"support":[146],"rationale":[148],"combining":[150],"agent":[153,157],"treatment":[160],"disease,":[163],"suggest":[165],"role":[167],"TNF":[169],"IFN":[172],"as":[174],"agents":[175],"stimulating":[177],"antitumor":[179],"macrophages.":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043296164","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
